Matches in Nanopublications for { ?s ?p "[Clinical studies in patients with solid tumors using a second-generation antisense oligonucleotide (GEM 231) targeted against protein kinase A type I.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[Clinical studies in patients with solid tumors using a second-generation antisense oligonucleotide (GEM 231) targeted against protein kinase A type I.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP592131.RAM8-ubC0UYS7YQWnqEBdBEegTOkXnGa4Z_I9LzBJNJlM130_assertion description "[Clinical studies in patients with solid tumors using a second-generation antisense oligonucleotide (GEM 231) targeted against protein kinase A type I.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP592131.RAM8-ubC0UYS7YQWnqEBdBEegTOkXnGa4Z_I9LzBJNJlM130_provenance.
- NP430045.RAVYDC9lQLqDKDrU-hCt6lqFMxCVYA1fmTi8a4Sp2faE4130_assertion description "[Clinical studies in patients with solid tumors using a second-generation antisense oligonucleotide (GEM 231) targeted against protein kinase A type I.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP430045.RAVYDC9lQLqDKDrU-hCt6lqFMxCVYA1fmTi8a4Sp2faE4130_provenance.
- NP430046.RAVJ646pyqgNRwZwjYcJqnqsKFPtByztL4BIBUVocC2x0130_assertion description "[Clinical studies in patients with solid tumors using a second-generation antisense oligonucleotide (GEM 231) targeted against protein kinase A type I.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP430046.RAVJ646pyqgNRwZwjYcJqnqsKFPtByztL4BIBUVocC2x0130_provenance.
- NP900811.RAAYMq0vEP2c81qauZQpWPiytsO86qEmUTXzYRaRFOuO4130_assertion description "[Clinical studies in patients with solid tumors using a second-generation antisense oligonucleotide (GEM 231) targeted against protein kinase A type I.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP900811.RAAYMq0vEP2c81qauZQpWPiytsO86qEmUTXzYRaRFOuO4130_provenance.
- NP422863.RAK4VMi9cW2h_SasixIgz2QPRufPH3U7J8u8RdwuwPj5I130_assertion description "[Clinical studies in patients with solid tumors using a second-generation antisense oligonucleotide (GEM 231) targeted against protein kinase A type I.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP422863.RAK4VMi9cW2h_SasixIgz2QPRufPH3U7J8u8RdwuwPj5I130_provenance.